Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.
Oncolytics Biotech's interim CEO to head company on a permanent basis
Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection
Japan M&A By the Numbers: Q4 2023
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.